![Dorman Followwill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dorman Followwill
Directeur/Bestuurslid bij
SCILEX HOLDING COMPANY
Vermogen: 507 $ op 30-06-2026
Profiel
Dorman Followwill is currently an Independent Director at Semnur Pharmaceuticals, Inc. since 2025, an Independent Director at Scilex Holding Co. since 2022, and a Senior Partner-Transformational Health at Frost & Sullivan, Inc. since 2016.
Former positions include Independent Director at Scilex, Inc. in 2022 and Independent Director at Sorrento Therapeutics, Inc. from 2017 to 2020.
Education includes an undergraduate degree from Stanford University conferred in 1985.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-04-2026 | 65 ( 0% ) | 507 $ | 30-06-2026 |
Actieve functies van Dorman Followwill
| Bedrijven | Functie | Begin |
|---|---|---|
| SCILEX HOLDING COMPANY | Directeur/Bestuurslid | 10-11-2022 |
Frost & Sullivan, Inc.
 Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Corporate Officer/Principal | 01-01-2016 |
Eerdere bekende functies van Dorman Followwill
| Bedrijven | Functie | Einde |
|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Directeur/Bestuurslid | 01-11-2022 |
| SORRENTO THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Opleiding van Dorman Followwill
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frost & Sullivan, Inc.
Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
